Aegon Completes Sale of Unirobe Meeùs Groep
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Allergen (AGN) PT Lowered to $221 at RBC Capital; Reiterates Outperform
November 2, 2017 8:39 AM EDTRBC Capital lowered its price target on Allergen (NYSE: AGN) to $221.00 (from $250.00) while maintaining a Outperform rating following the company's 3Q earnings report.
Analyst Randall Stanicky still sees unlocked value and expect shareholder pressure to increase and add share support especially if that... More
Allergan (AGN) Should Be Up - Evercore ISI's Raffat
November 1, 2017 10:34 AM EDTEvercore ISI analyst Umer Raffat argues that Allergan (NYSE: AGN) stock should be up and thinks the call went well.
Raffat notes management was very clear about expectations into next year. They also provided clarity on milestone payments etc. over next few years.
From his perspective, the 3 most important things on the call... More
